Statistics for Adjuvant autologous melanoma vaccine for macroscopic stage III disease: survival, biomarkers, and improved response to CTLA-4 blockade
Total visits
| views | |
|---|---|
| Adjuvant autologous melanoma vaccine for macroscopic stage III disease: survival, biomarkers, and improved response to CTLA-4 blockade | 1 |
Total visits per month
| views | |
|---|---|
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease Survival, Biomarkers, and Improved Response to CTLA-4 Blockade.pdf | 26 |
Top country views
| views | |
|---|---|
| United States | 1 |
Top city views
| views | |
|---|---|
| Boardman | 1 |